BioTelemetry (BEAT) Tops Q1 EPS by 2c; Withdraws Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
BioTelemetry, Inc. Reports First Quarter 2020 Financial Results
May 6, 2020 4:05 PM EDTMALVERN, Pa., May 06, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the quarter ended March 31, 2020.
Quarter Highlights
Recognized quarterly revenue of $113.0 millionReached 8.7% year-over-year quarterly revenue growthAchieved 31st consecutive quarter of year-over-year revenue growthReported quarterly GAAP net income of $7.1 million, or 6.3% of revenueRealized quarterly adjusted EBITDA of $29.5 million, or 26.1% of revenue... More